VIRUCID 800MG TABLETS

국가: 사이프러스

언어: 그리스어

출처: Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

유효 성분:

ACICLOVIR

제공처:

DELORBIS PHARMACEUTICALS LTD (0000009620) 17 ATHINON STREET, ERGATES INDUSTRIAL AREA, LEFKOSIA, 2081, 28629

ATC 코드:

J05AB01

INN (국제 이름):

ACICLOVIR

복용량:

800MG

약제 형태:

TABLETS

구성:

ACICLOVIR (0059277893) 800MG

관리 경로:

ORAL USE

처방전 유형:

Εθνική Διαδικασία

치료 영역:

ACICLOVIR

제품 요약:

Νομικό καθεστώς: Με Ιατρική Συνταγή; PACK WITH 36 TABS IN BLISTER(S) (950003803) 36 TABLET - Εγκεκριμένο - Με Ιατρική Συνταγή

환자 정보 전단

COMPARATIVE TABLE – ENGLISH PIL VS GREEK PIL
PACKAGE LEAFLET: INFORMATION FOR THE USER
VIRUCID 800 MG TABLETS
Aciclovir
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE
BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their signs of illness are the same
as
yours.

If you get any side effects talk to your doctor or pharmacist. This
includes any possible side effects not listed in this leaflet. See
section 4.
WHAT IS IN THIS LEAFLET
1.
What Virucid is and what it is used for
2.
What you need to know before you take Virucid
3.
How to take Virucid
4.
Possible side effects
5.
How to store Virucid
6.
Contents of the pack and other information
1. WHAT VIRUCID IS AND WHAT IT IS USED FOR
ΦΎΛΛΟ ΟΔΗΓΙΏΝ ΧΡΉΣΗΣ: ΠΛΗΡΟΦΟΡΊΕΣ ΓΙΑ
ΤΟΝ ΧΡΉΣΤΗ
VIRUCID 800 MG ΔΙΣΚΊΑ
Ακυκλοβίρη
ΔΙΑΒΆΣΤΕ ΠΡΟΣΕΚΤΙΚΆ ΟΛΌΚΛΗΡΟ ΤΟ ΦΎΛΛΟ
ΟΔΗΓΙΏΝ ΧΡΉΣΗΣ ΠΡΟΤΟΎ
ΑΡΧΊΣΕΤΕ ΝΑ ΠΑΊΡΝΕΤΕ ΑΥΤΌ ΤΟ ΦΆΡΜΑΚΟ,
ΔΙΌΤΙ ΠΕΡΙΛΑΜΒΆΝΕΙ ΣΗΜΑΝΤΙΚΈΣ
ΠΛΗΡΟΦΟΡΊΕΣ ΓΙΑ ΣΑΣ.

Φυλάξτε αυτό το φύλλο οδηγιών χρήσης.
Ίσως χρειαστεί να το
διαβάσετε ξανά.

Εάν έχετε περαιτέρω απορίες, ρωτήστε
τον γιατρό ή τον φαρμακοποιό
σας.

Η συνταγή για αυτό το φάρμακο
χορηγήθηκε αποκλειστικά για σας. Δεν
πρέπει να δώσετε το φάρμακο σε άλλους.
Μπορεί να τους προκαλέσει
βλάβη, ακόμα και όταν τα συμπτώματα
της ασθένειάς τους είναι ίδια με
τα δικά σας.

Εάν παρα

제품 특성 요약

SUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE MEDICINAL PRODUCT
Virucid 800 mg Tablets
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 800 mg of aciclovir.
For a full list of excipients, see section 6.1.
3. PHARMACEUTICAL FORM
Tablets
4. CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Virucid 800 mg tablets are indicated for the treatment of varicella
(chickenpox) and herpes zoster
(shingles) infections (excluding neonatal HSV and severe HSV
infections in immunocompromised
children).
Virucid 800 mg is recommended in children over the age of 6.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Dosage in adults:
1
Treatment of varicella and herpes zoster infections: 800 mg Virucid
should be taken five times daily at
approximately four-hourly intervals, omitting the night time dose.
Treatment should continue for seven
days.
In severely immunocompromised patients (e.g. after marrow transplant)
or in patients with impaired
absorption from the gut, consideration should be given to intravenous
dosing.
Dosing should begin as early as possible after the start of an
infection: Treatment of herpes zoster yields
better results if initiated as soon as possible after the onset of the
rash. Treatment of chickenpox in
immunocompetent patients should begin within 24 hours after the onset
of the rash.
Dosage in children:
Treatment of varicella infections:
6 years and over: 800 mg Virucid four times daily.
Treatment should continue for five days.
No specific data are available on the treatment of herpes zoster
infections in immunocompetent children.
For treatment of neonatal herpes virus infections, intravenous
acyclovir is recommended.
Dosage in the elderly:
The possibility of renal impairment in the elderly must be considered
and the dosage should be adjusted
accordingly (see Dosage in renal impairment below).
Adequate hydration of elderly patients taking high oral doses of
aciclovir should be maintained.
Dosage in renal impairment:
Caution is advised when administering aciclovir to patients with
impaired renal func